Another plus for Statins- May help treat xanthelasmas Dr. Kamal Kant Kohli19 Feb 2020 11:28 AM ISTXanthelasmas are asymptomatic, benign, yellowish papules or plaques that appear on or around the eyelids. They comprise of cholesterol-loaded...
Eplerenone not beneficial for treatment of central serous chorioretinopathy: Lancet Medha Baranwal18 Feb 2020 5:30 PM ISTUK: Eplerenone, a drug widely used for the treatment of central serous chorioretinopathy (CSCR), is not beneficial and should no longer be used, a...
Teprotumumab improves symptoms and quality of life in thyroid eye disease patients Dr. Kamal Kant Kohli11 Feb 2020 6:00 PM ISTLOS ANGELES -- Researchers at Cedars-Sinai and at other medical centers nationwide have found that minimally invasive insulin-like growth factor I...
Study closely links protein to age-related macular degeneration Dr. Kamal Kant Kohli10 Feb 2020 3:30 PM ISTUK: A new Study closely links Protein to age-related macular degeneration.A team from Universities of Manchester, Cardiff, London and Nijmegen, and...
Attention Ophthalmologists: Sightsavers India invites applications for India Fellowship Program 2020 Medical Dialogues Bureau10 Feb 2020 12:00 PM ISTYou can apply for the Sightsavers India Fellowship Program before April 30th 2020.
Viagra use linked to visual disturbances in new study Dr. Kamal Kant Kohli10 Feb 2020 11:45 AM ISTUse of Sidenifil with common brand Viagra has been liked to vision disturbances including light sensitivity and color vision impairment in a new...
Researchers develop Novel lenses that self moisturise to prevent dry eye disease Dr. Kamal Kant Kohli24 Jan 2020 9:45 AM ISTSmart contact lenses are the order of the day and these wearable devices that could accelerate vision beyond natural human capabilities. They are...
Researchers develop a novel test that can predict Glaucoma risk by analysing DNA Hina Zahid23 Jan 2020 11:49 AM ISTGlaucoma is a group of diseases that are characterized by progressive damage and degeneration of the optic nerve, causing gradual loss of vision.
US FDA approves Tepezza- first treatment for thyroid eye disease MD Bureau22 Jan 2020 10:32 AM ISTUS : The U.S. Food and Drug Administration (FDA) has given its nod to Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye...
Binocular treatment no better than patching for amblyopia Medha Baranwal20 Jan 2020 11:45 AM ISTUSA: Binocular treatments of amblyopia cannot be recommended as a replacement for standard treatments (including patching and optical treatment), a...
